News

Civitas Resources Sees Price Target Increase by JPMorgan Chase

Civitas Resources Sees Price Target Increase by JPMorgan Chase

JPMorgan Adjusts Price Target for Civitas Resources

JPMorgan has made a notable adjustment to its outlook on Civitas Resources (NYSE: CIVI), elevating the stock's price target from $67.00 to $70.00 while continuing to uphold an Overweight rating on the shares. This move underscores the firm’s confidence in Civitas's operational performance.

Strong Expectations for Q3 Operations

The firm anticipates a strong operational quarter for Civitas, with oil production estimates aligning with market expectations. The forecast for the upcoming quarter projects cash flow per share (CFPS) at $7.94, slightly trailing the Wall Street consensus of $8.21. This revision follows an updated market assessment for third-quarter commodity prices.

EBITDA and Production Estimates

JPMorgan estimates Civitas's earnings before interest, taxes, depreciation, and amortization (EBITDA) at $902 million, which is a modest 3% lower than the expected $923 million. Notably, the bank anticipates that oil production will achieve an impressive 161.3 thousand barrels per day (MBo/d), outpacing the Wall Street forecast.

Capital Expenditure Insights

The total production estimate is set at 349.4 thousand barrels of oil equivalent per day (MBoe/d), exceeding the Street's prediction of 345.9 MBoe/d. This optimistic outlook includes expectations of a slight quarter-over-quarter increase in natural gas and natural gas liquids (NGLs).

Future Capital Plans

In terms of capital expenditures (capex), JPMorgan projects $399 million for the third quarter, representing a 4% increase over the Street's estimate of $382 million. However, a lower capex estimate of $300 million is anticipated for the fourth quarter, which is an 8% decrease by comparison to the Street's expectation of $327 million. For the full year of 2024, JPMorgan's capex estimate totals $1.92 billion, which closely corresponds to the Street's target of $1.90 billion.

Free Cash Flow Generation

Civitas is projected to generate an impressive $397 million in free cash flow (FCF) during the third quarter. After the second-quarter earnings report, the company revised its cash return strategy to provide flexibility for share buybacks and variable dividends. Currently, JPMorgan estimates that 80% of Civitas's variable returns in the third quarter will be allocated to share repurchases, amounting to approximately $79 million.

Long-Term Financial Outlook

Looking further into the future, JPMorgan predicts Civitas will generate sizable free cash flow amounts of $1.19 billion and $1.18 billion for fiscal years 2025 and 2026, respectively. This would yield a noteworthy free cash flow yield of around 26%, based on recent strip prices hovering around $68 and $66 per barrel.

Recent Developments and Growth Performance

In recent months, Civitas Resources has shown tremendous improvement in both financial and operational standings. The energy company achieved a robust second quarter in 2024, marked by increased production levels and lowered costs, primarily due to its strategic expansion into the Permian Basin. This initiative has led to a production boost of 12%, alongside a 5% increase in oil output, surpassing prior estimates.

Shareholder Returns and Commitment

The company has also introduced a substantial share repurchase initiative, committing $1.5 billion to returning value to shareholders. Alongside this, Civitas aims to produce over $900 million in free cash flow in the latter half of 2024, aligning with its goals of cost efficiency and operational optimization.

Analysts' Ratings and Market Perception

Analysts' responses to these promising developments show JPMorgan assigning a favorable Overweight rating to Civitas. Meanwhile, Mizuho Securities has maintained an Outperform rating, albeit with a reduced price target of $84. In contrast, Truist Securities has upped its price target to $101 while maintaining a Buy rating.

Frequently Asked Questions

What is the new price target set by JPMorgan for Civitas Resources?

JPMorgan raised the price target for Civitas Resources from $67.00 to $70.00.

How does JPMorgan view Civitas's operational performance?

JPMorgan holds an Overweight rating on Civitas and expects a strong operational quarter.

What are the free cash flow projections for Civitas?

Civitas is projected to generate $397 million in free cash flow in Q3 and $1.19 billion in 2025.

How much is Civitas investing in capital expenditures for Q3?

JPMorgan estimates Civitas's capital expenditures for Q3 to be $399 million.

What have been the recent strategic developments for Civitas?

Civitas has expanded into the Permian Basin and introduced a $1.5 billion share repurchase plan.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Legal Action Announced for Investors of Synopsys, Inc.

Updated Category News Views 132

Class Action Overview for Synopsys, Inc. Investors The Portnoy Law Firm has stepped forward to support investors of Synopsys, Inc., a prominent player in the software industry known for its electronic design automation solutions. Investors who purchased securities between December 4, 2024, and September 9, 2025, are being invited to participate in a class action lawsuit....

Continue Reading
Welcome New Members to the SIG Shooter Affiliate Program

Updated Category News Views 93

Welcoming New Affiliates to the SIG Shooter Program SIG SAUER is thrilled to announce the addition of Tre'Von Barber, Kaylee Lane, and Todd Sindelar to the SIG Shooter Affiliate Program. This exciting initiative, slated to begin soon, aims to bolster their representation at significant competitive shooting events across the nation. Introducing Tre'Von Barber Tre'Von...

Continue Reading
MassageLuXe Expands DFW Presence with New Spa Locations

Updated Category News Views 312

MassageLuXe Expands Its Presence in Dallas-Fort Worth Region MassageLuXe, a renowned luxury spa franchise, is set to make waves in the Dallas-Fort Worth region. With plans to launch more than 20 new locations, this strategic growth initiative aims to tap into the increasing demand for wellness and self-care services across the area. A New Era of Self-Care In recent years,...

Continue Reading
Exciting Growth Ahead for the Ceramic Fiber Market

Updated Category News Views 150

The ceramic fiber market was gearing up for a substantial leap, eyeing a worth of $3.5 billion by 2029, with a robust CAGR of 8.6% from 2024 onward. Traders were already buzzing about the heat resistance and low thermal conductivity that made these fibers prime players across several industries. Drivers of Ceramic Fiber Market Growth: Energy Efficiency & Sustainability...

Continue Reading
Promising Insights on HOPE Technology for Liver Health

Updated Category News Views 138

Innovative HOPE Technology in Liver Transplantation Recent research from Italy has been diving into Hypothermic Oxygenated Perfusion (HOPE), showcasing its safety in liver transplants and its potential to improve patient outcomes. These studies were presented during a major international congress, marking a significant milestone in the field. Researchers are excited about...

Continue Reading